Laurence Busse MD
- Department of Medicine
Associate Professor
-
Emory Johns Creek Hospital
Intensive Care Unit
6325 Hospital Parkway
Overview
Dr. Busse completed his medical education at George Washington University, where he stayed on for his Internal Medicine residency, and fellowship training in Critical Care Medicine. He worked as an Intensivist in northern Virginia before joining Emory University in 2016 as the Medical Director of critical care at Emory Saint Josephs Hospital. He currently serves as Medical Director for critical care at Emory Johns Creek Hospital. Prior to his medical career, Dr. Busse received his Masters degree in Business Administration from Emory University. Dr. Busses areas of research and interest include the examination of the sequelae of high output shock, including catecholamine resistant hypotension and acute kidney injury. He has been involved in early clinical work exploring the use of angiotensin II as a novel therapeutic agent in catecholamine resistant hypotension. He is actively engaged as an intensivist and supervises trainees in Emory Johns Creek Hospitals intensive care unit.
Academic Appointment
- Assistant Professor, Pulmonary, Critical Care, Allergy and Sleep Medicine, Emory University
Education
Degrees
- M.D. from George Washington University
- M.B.A. from Emory University
- B.A. from Tulane University
Research
Publications
-
Modulation of the renin-angiotensin system against COVID-19: A path forward?
Int J Infect Dis Volume: 154 Page(s): 107867
05/01/2025 Authors: Camelo S; Dioh W; Teixeira JP; Busse LW; Nair G; Plantefeve G; Morelot-Panzini C; Lobo SM; Self WH; Collins SP -
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination.
JAMA Netw Open Volume: 8 Page(s): e252841
04/01/2025 Authors: Surie D; Yuengling KA; Safdar B; Ginde AA; Peltan ID; Brown SM; Gaglani M; Ghamande S; Gottlieb RL; Columbus C -
COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United States, 2019-2022.
Vaccine Volume: 48 Page(s): 126806
02/27/2025 Authors: Khan A; Zhu Y; Babcock HM; Busse LW; Duggal A; Exline MC; Gaglani M; Gibbs KW; Gong MN; Ginde AA -
Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19-Associated Venous Thromboembolism.
J Infect Dis Volume: 231 Page(s): 378 - 385
02/20/2025 Authors: Hager DN; Zhu Y; Sohn I; Stubblefield WB; Streiff MB; Gaglani M; Steingrub JS; Duggal A; Felzer JR; O'Rourke M -
An index of the initial blood pressure response to angiotensin II treatment and its association with clinical outcomes in vasodilatory shock.
Crit Care Volume: 29 Page(s): 81
02/19/2025 Authors: Leisman DE; Wieruszewski PM; Busse LW; Chawla LS; Hibbert KA; Handisides DR; Khanna AK; Ostermann M; McCurdy MT; Adams CD -
Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19.
J Crit Care Volume: 85 Page(s): 154950
02/01/2025 Authors: Busse LW; Teixeira JP; Schaich CL; Ten Lohuis CC; Nielsen ND; Sturek JM; Merck LH; Self WH; Puskarich MA; Khan A -
Higher circulating ACE2 and DPP3 but reduced ACE and angiotensinogen in hyperreninemic sepsis patients.
Clin Sci (Lond) Volume: 139 Page(s): 43 - 53
01/15/2025 Authors: Chappell MC; Schaich CL; Busse LW; Clark Files D; Martin GS; Sevransky JE; Hinson JS; Rothman RE; Khanna AK; Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Investigators -
Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational study.
Clin Infect Dis
11/28/2024 Authors: Lewis NM; Harker EJ; Grant LB; Zhu Y; Grijalva CG; Chappell JD; Rhoads JP; Baughman A; Casey JD; Blair PW -
Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.
Influenza Other Respir Viruses Volume: 18 Page(s): e70027
11/01/2024 Authors: DeCuir J; Surie D; Zhu Y; Lauring AS; Gaglani M; McNeal T; Ghamande S; Peltan ID; Brown SM; Ginde AA -
Stronger association of intact angiotensinogen with mortality than lactate or renin in critical illness: post-hoc analysis from the VICTAS trial.
Crit Care Volume: 28 Page(s): 333
10/14/2024 Authors: Chappell MC; Schaich CL; Busse LW; Martin GS; Sevransky JE; Hinson JK; Khanna AK; Vitamin C, Thiamine, Steroids in Sepsis (VICTAS) Investigators